News — Optic Neuritis
Treating Neuromyelitis Optica: Relapse Management and Prevention
AQP4 antibodies autoimmune disorders biologics for NMO corticosteroids for NMO Devic disease eculizumab immunosuppressive therapy inebilizumab long-term NMO care neurologic disability prevention neuromyelitis optica NMO flare treatment NMO relapse management NMO treatment NMO vs MS optic neuritis plasma exchange NMO satralizumab transverse myelitis
Neuromyelitis optica (NMO), also known as Devic’s disease, is a rare autoimmune disorder that targets the optic nerves and spinal cord. Characterized by sudden and often severe relapses, it can cause vision loss, paralysis, and long-term disability if not treated swiftly and appropriately. Unlike multiple sclerosis (MS), NMO is driven by a different mechanism—typically involving antibodies against aquaporin-4 (AQP4), a water channel protein found in the central nervous system.
Managing NMO involves two equally critical fronts: addressing acute relapses as they occur, and implementing long-term strategies to prevent future attacks. With the right approach, many patients can achieve stability and preserve neurological function. This guide breaks down the key principles of treating NMO, from immediate crisis care to proactive prevention that supports quality of life over time.
Glatiramer Acetate vs. Other MS Medications: Choosing the Right Treatment
disease-modifying drugs Glatiramer Acetate MS Fatigue MS medications MS Primary Progressive MS Progressive-Relapsing MS Relapsing-Remitting MS Secondary Progressive MS Symptoms MS treatment options Multiple Sclerosis Optic Neuritis
Multiple Sclerosis (MS) is a chronic neurological condition requiring tailored treatment strategies. Among the many available options, Glatiramer Acetate (GA) has been a cornerstone of MS management.
However, it faces competition from newer therapies like oral disease-modifying drugs (DMDs) and monoclonal antibodies. This article explores the distinctions, benefits, and challenges of Glatiramer Acetate compared to other MS medications to help patients and healthcare providers make informed choices.